Recombinant Human CTSD protein, GST-tagged

• Cat.No.: CTSD-2758H
• Product Overview: Recombinant Human CTSD protein(P07339)(67-403aa), fused to N-terminal GST tag, was expressed in E. coli.

Specification

• Source: E. coli
• Species: Human
• Tag: GST
• Form: If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
  If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
• Molecular Mass: 63.8 kDa
• Protein length: 67-403aa
• AA Sequence: IPEVLKNYMDAQYYGEIGIGTPPQC FTVVFDTGSSNLWVPSIHCKLLDIA CWIHHKYNSDKSSTYVKNGTSFDIH YGSGSLSGYLSQDTVSVPCQSASSA SALGGVKVERQVFGEATKQPGITFI AAKFDGILGMAYPRISVNNVLPVFD NLMQQKLVDQNIFSFYLSRDPDAQP GGELMLGGTDSKYYKGSLSYLNVTR KAYWQVHLDQVEVASGLTLCKEGCE AIVDTGTSLMVGPVDEVRELQKAIG AVPLIQGEYMIPCEKVSTLPAITLK LGGKGYKLSPEDYTLKVSQAGKTLC LSGFMGMDIPPPSGPLWILGDVFIG RYYTVFDRDNNR
• Purity: Greater than 90% as determined by SDS-PAGE.
• Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
• Reconstitution: Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%.

Gene Information

• Gene Name: CTSD cathepsin D [ Homo sapiens ]
• Official Symbol: CTSD
• Synonyms: CTSD; cathepsin D; cathepsin D (lysosomal aspartyl protease) , CPSD; ceroid lipofuscinosis; neuronal 10; CLN10; lysosomal aspartyl protease; lysosomal aspartyl peptidase; ceroid-lipofuscinosis, neuronal 10; CPSD; MGC2311
• Gene ID: 1509
• mRNA Refseq: NM_001909
• Protein Refseq: NP_001900
• MIM: 116840
• UniProt ID: P07339

Reviews

07/12/2021

Good at western-blot experiments.

03/28/2021

In experiments, the biocompatibility performed well.

03/02/2021

The experimental conditions are broad, and the experimental results are accurate and repeatable.

Q&As

What is the relationship between CTSD proteins and cognitive function?

There is an association between CTSD proteins and cognitive function. In some neurodegenerative diseases, abnormal accumulation and deposition of CTSD proteins may affect neuronal signaling and synaptic function, leading to a decline in cognitive function.

What is the relationship between changes in CTSD protein levels and disease?

In some neurodegenerative diseases, levels of the CTSD protein may change. For example, people with Alzheimer's disease may have elevated levels of the CTSD protein. These changes may help in the diagnosis of the disease and in the assessment of the course of the disease.

For people with cognitive decline, how do you assess their CTSD protein levels?

For people with cognitive decline, their CTSD protein levels can be assessed by a blood or cerebrospinal fluid sample. This evaluation can help doctors understand whether the cause of cognitive decline is related to a neurodegenerative disease.

How can treatment be used to alter the level or function of the CTSD protein?

It is currently no treatment that directly targets the CTSD protein. However, some medications can reduce symptoms of neurodegenerative diseases, such as cholinesterase inhibitors such as donepezil, which can increase acetylcholine levels in synapses, which can improve cognitive function.

Is CTSD protein involved in Parkinson's disease?

People with Parkinson's disease may have reduced levels of the CTSD protein. This decrease may be associated with neuronal death and impaired synaptic function. In addition, CTSD protein may also be associated with motor symptoms in patients with Parkinson's disease.

In which diseases does the CTSD protein play a role?

CTSD proteins play a role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. It may change in these diseases, leading to structural alterations and impaired signaling of neuronal synapses.